Cover Image
市場調查報告書

結核診斷的全球市場:2015年∼2019年

Global TB Diagnostic Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 336107
出版日期 內容資訊 英文 82 Pages
訂單完成後即時交付
價格
Back to Top
結核診斷的全球市場:2015年∼2019年 Global TB Diagnostic Market 2015-2019
出版日期: 2015年07月22日 內容資訊: 英文 82 Pages
簡介

全球結核診斷市場,預計從2014年到2019年,以2.97%的年複合成長率擴大。

本報告提供全球結核診斷市場概況與今後的預測、技術趨勢、市場成長因素與課題、主要趨勢、主要企業簡介等資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 盛行率及罹患率

第8章 技術的進步

  • 第2代核酸檢測
  • 下一代核酸檢測

第9章 結核診斷的開發平台

第10章 各病期的市場分類

  • 潛伏期間的診斷
  • 活動期間的診斷
  • 藥物敏感性實驗

第11章 地理區分

  • 亞太地區
    • 印度
  • 南北美洲
    • 巴西
  • 歐洲、中東、非洲地區
    • 南非

第12章 購買標準

第13章 市場成長因素

第14章 成長因素與其影響

第15章 市場課題

第16章 成長因素與課題的影響

第17章 市場趨勢

第18章 趨勢與其影響

第19章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 市場佔有率分析
    • Abbott Diagnostics
    • Alere
    • BD
    • Roche Diagnostics
  • 其他卓越供應商

第20章 主要供應商分析

  • Abbott Diagnostics
  • Alere
  • BD
  • Roche Diagnostics

第21章 相關報告

目錄
Product Code: IRTNTR6506

About TB Diagnostics

TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world's deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.

The symptoms of active TB of the lung include coughing, occasionally with sputum or blood, weakness, chest pains, weight loss, fever, and night sweats. Though the disease is preventive in developed countries, there is a shortage of efficient diagnosis tools and detection in developing countries.

Technavio's analysts forecast the global TB diagnostic market to grow at a CAGR of 2.97% during the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global TB diagnostic market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of TB diagnostic products in the market.

Technavio's report, Global TB Diagnostic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global TB diagnostics market landscape and its growth prospects over the coming years. The report includes a discussion of the key vendors operating in this market.

Key Geographies

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott
  • Alere
  • Becton, Dickinson
  • F. Hoffmann-La Roche

Other Prominent Vendors

  • Siemens
  • BioMerieux
  • Cepheid
  • Hain Lifescience
  • Hologic
  • Ortho Clinical
  • Epistem UK
  • Eiken Chemical Japan
  • Alere US

Market Driver

  • High Prevalence of TB
  • For a full, detailed list, view our report

Market Challenge

  • Insensitivity of Spear Microscopy
  • For a full, detailed list, view our report

Market Trend

  • Intensification of Rapid Tests in Developing Countries
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Prevalence and Incidence Rate

08. Advances in Technology

  • 08.1. Second-generation Nucleic Acid Detection
  • 08.2. Next-generation Nucleic Acid Detection

09. TB Diagnostics Pipeline

10. Market Segmentation by Disease Stage

  • 10.1. Global Latent TB Diagnostics Market
  • 10.2. Global Active TB Diagnostics Market
  • 10.3. Global Drug Susceptibility Tests Market

11. Geographical Segmentation

  • 11.1. Global TB Diagnostics Market in APAC
    • 11.1.1. India
  • 11.2. Global TB Diagnostics Market in Americas
    • 11.2.1. Brazil
  • 11.3. Global TB Diagnostics Market in EMEA
    • 11.3.1. South Africa

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and Their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and Their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2013
    • 19.2.1. Abbott Diagnostics
    • 19.2.2. Alere
    • 19.2.3. BD
    • 19.2.4. Roche Diagnostics
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Diagnostics
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Geographical Presence
    • 20.1.4. SWOT Analysis
  • 20.2. Alere
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Business Segmentation by Revenue 2013
    • 20.2.4. Business Segmentation by Revenue 2012 and 2013
    • 20.2.5. Geographical Segmentation by Revenue 2013
    • 20.2.6. Business Strategy
    • 20.2.7. Recent Developments
    • 20.2.8. SWOT Analysis
  • 20.3. BD
    • 20.3.1. Key Facts
    • 20.3.2. Business Description
    • 20.3.3. Business Segmentation
    • 20.3.4. Revenue Segmentation by Business
    • 20.3.5. Segmental Revenue Comparison 2013 and 2012
    • 20.3.6. Revenue Segmentation by Geography
    • 20.3.7. Business Strategy
    • 20.3.8. Key Developments
    • 20.3.9. SWOT Analysis
  • 20.4. Roche Diagnostics
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation by Revenue 2014
    • 20.4.4. Business Segmentation by Revenue 2013 and 2014
    • 20.4.5. Geographical Segmentation by Revenue 2014
    • 20.4.6. Business Strategy
    • 20.4.7. Recent Developments
    • 20.4.8. SWOT Analysis

21. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global TB Diagnostics Market 2014-2019 ($ millions)
  • Exhibit 3: Incidence Rate per 100,000 Individuals 2013
  • Exhibit 4: High-burden Countries
  • Exhibit 5: Product Pipeline: TB Diagnostics
  • Exhibit 6: Segmentation of Global Active TB Diagnostics Market 2014
  • Exhibit 7: Segmentation of Global TB Diagnostics Market by Disease Stage 2014
  • Exhibit 8: Segmentation of Global TB Diagnostics Market by Geography 2014
  • Exhibit 9: India: Revenue Segmentation by Entity 2012
  • Exhibit 10: Public Sector: Segmentation of TB Diagnostics by Revenue 2012
  • Exhibit 11: Private Sector: Segmentation of TB Diagnostics by Revenue 2012
  • Exhibit 12: Brazil: Revenue Segmentation by Entity 2012
  • Exhibit 13: Brazil: Common TB Diagnostic Tests and Their Cost 2012
  • Exhibit 14: Brazil: Segmentation of TB Diagnostic Tests by Revenue 2012-2013
  • Exhibit 15: South Africa: Revenue Segmentation of TB Diagnostic Tests by Entity 2012-2013
  • Exhibit 16: Diagnostic Tests and Costs by Sectors
  • Exhibit 17: South Africa: Segmentation of TB by Revenue 2012-2013
  • Exhibit 18: South Africa: Volume of Tests in Public Sector 2012-2013
  • Exhibit 19: South Africa: Volume of Tests in Private Sector 2012-2013
  • Exhibit 20: Key Takeaways: Abbott Diagnostics
  • Exhibit 21: Key Takeaways: Alere
  • Exhibit 22: Key Takeaways: BD
  • Exhibit 23: Key Takeaways: Roche Diagnostics
  • Exhibit 24: Abbott Diagnostics: Geographical Presence
  • Exhibit 25: Alere: Business Segmentation by Revenue 2013
  • Exhibit 26: Alere: Business Segmentation by Revenue 2012 and 2013 ($ billions)
  • Exhibit 27: Alere: Geographical Segmentation by Revenue 2013
  • Exhibit 28: Product Categorization of BD
  • Exhibit 29: Revenue Segmentation of BD 2013
  • Exhibit 30: Revenue Comparison ($ millions)
  • Exhibit 31: Revenue Segmentation of BD by Geography 2013
  • Exhibit 32: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 33: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
  • Exhibit 34: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Back to Top